The Lancet Respiratory Medicine published a phase 2 clinical study article on China's first DPP-1 inhibitor, HSK31858, led by ...

People with bronchiectasis can often produce sputum on a daily basis, reflecting an ongoing inflammation and poor local defence mechanisms. The inflamed tubes of the lungs are often inhabited by ...

The FDA has started a priority review of Insmed's brensocatib, which is pitching to become the first approved therapy for chronic lung disease bronchiectasis in the US. The regulator has set a ...

interstitial lung disease, bronchiectasis, benign and malignant neoplasms, and lung transplantation. The Lung Institute has developed a comprehensive program across specialties with one site for ...

Surgery is essential for the effective management of bronchiectasis. Segmentectomy, while a challenging procedure, has become ...

One of the most striking claims in the review is that AI-based classification models can meet or exceed the performance of ...

Visakhapatnam: Researchers at the department of forensic medicine and toxicology at Andhra Medical College, Visakhapatnam, conducted an in-depth analy.

It is estimated that some 300,000 people in the UK have bronchiectasis, a devastating chronic lung condition that causes excess mucus to build up in the lungs, resulting in frequent coughing and ...

This involves removing diseased tissue to alleviate symptoms and improve lung function. During the procedure, the patient is positioned on their side, and an S-shaped thoracotomy incision is made. The ...

today announced its submission of an amended statistical analysis plan to the FDA selecting the Quality of Life – Bronchiectasis (QOL-B) respiratory domain patient reported outcome (PRO ...